SANTINI, ALAN
SANTINI, ALAN
QUVI - DIPARTIMENTO DI SCIENZE PER LA QUALITA' DELLA VITA
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease
2025 Santini, Alan; Tassinari, Elisa; Altomare, Alessandra; Loi, Manuela; Ciani, Elisabetta; Trazzi, Stefania; Piccarducci, Rebecca; Daniele, Simona; Martini, Claudia; Pagliarani, Barbara; Tarozzi, Andrea; Bersani, Matteo; Spyrakis, Francesca; Danková, Daniela; Poeta, Eleonora; Raimondi, Simone; Davani, Lara; Aldini, Giancarlo; Andrisano, Vincenza; De Simone, Angela; Milelli, Andrea
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease
2024 Santini, A.; Tassinari, E.; Poeta, E.; Loi, M.; Ciani, E.; Trazzi, S.; Piccarducci, R.; Daniele, S.; Martini, C.; Pagliarani, B.; Tarozzi, A.; Bersani, M.; Spyrakis, F.; Danková, D.; Olsen, C. A.; Soldati, R.; Tumiatti, V.; Montanari, S.; De Simone, A.; Milelli, A.
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer
2024 Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A.
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
2023 Guardigni M.; Pruccoli L.; Santini A.; Simone A.D.; Bersani M.; Spyrakis F.; Frabetti F.; Uliassi E.; Andrisano V.; Pagliarani B.; Fernández-Gómez P.; Palomo V.; Bolognesi M.L.; Tarozzi A.; Milelli A.
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION
2022 Santini, A.; Pruccoli, L.; Guardigni, M.; De Simone, A.; Spyrakis, F.; Frabetti, F.; Andrisano, V.; Bolognesi, M. L.; Tarozzi, A.; Milelli, A.
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer
2020 Catanzaro E.; Betari N.; Arencibia J.M.; Montanari S.; Sissi C.; De Simone A.; Vassura I.; Santini A.; Andrisano V.; Tumiatti V.; De Vivo M.; Krysko D.V.; Rocchi M.B.L.; Fimognari C.; Milelli A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease | Santini, Alan; Tassinari, Elisa; Altomare, Alessandra; Loi, Manuela; Ciani, Elisabetta; Trazzi, S...tefania; Piccarducci, Rebecca; Daniele, Simona; Martini, Claudia; Pagliarani, Barbara; Tarozzi, Andrea; Bersani, Matteo; Spyrakis, Francesca; Danková, Daniela; Poeta, Eleonora; Raimondi, Simone; Davani, Lara; Aldini, Giancarlo; Andrisano, Vincenza; De Simone, Angela; Milelli, Andrea | 2025-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | AR-A014418-based dual Glycogen Synthase Kinase 3β_Histone Deacetylase inhibitors as potential therapeutics for Alzheimer_s disease.pdf; 1-s2.0-S0223523425006038-mmc1.docx |
| First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease | Santini, A.; Tassinari, E.; Poeta, E.; Loi, M.; Ciani, E.; Trazzi, S.; Piccarducci, R.; Daniele, ...S.; Martini, C.; Pagliarani, B.; Tarozzi, A.; Bersani, M.; Spyrakis, F.; Danková, D.; Olsen, C. A.; Soldati, R.; Tumiatti, V.; Montanari, S.; De Simone, A.; Milelli, A. | 2024-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | acs-cn.pdf |
| Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer | Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone... A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A. | 2024-01-01 | RSC MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | d4md00175c.pdf; d4md00175c1.pdf |
| PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease | Guardigni M.; Pruccoli L.; Santini A.; Simone A.D.; Bersani M.; Spyrakis F.; Frabetti F.; Uliassi... E.; Andrisano V.; Pagliarani B.; Fernández-Gómez P.; Palomo V.; Bolognesi M.L.; Tarozzi A.; Milelli A. | 2023-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | acschemneuro.3c00096.pdf |
| PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION | Santini, A.; Pruccoli, L.; Guardigni, M.; De Simone, A.; Spyrakis, F.; Frabetti, F.; Andrisano, V....; Bolognesi, M. L.; Tarozzi, A.; Milelli, A. | 2022-01-01 | - | - | 4.03 Poster | - |
| Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer | Catanzaro E.; Betari N.; Arencibia J.M.; Montanari S.; Sissi C.; De Simone A.; Vassura I.; Santin...i A.; Andrisano V.; Tumiatti V.; De Vivo M.; Krysko D.V.; Rocchi M.B.L.; Fimognari C.; Milelli A. | 2020-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | Draft_revised_Milelli no copertina.pdf |